Finance
Results: 865-876 of 31098

Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status

SprintRay Acquires EnvisionTEC Dental Product Portfolio, Expanding Commitment to 3D Printing in Dentistry
